How Insurers Assess Risk in Medical Device Manufacturing

Introduction

Medical device manufacturing sits at the crossroads of patient safety, strict regulation, complex supply chains, and high-value products. For insurers, that mix can mean large claims if something goes wrong—but it can also mean well-run, process-driven businesses that manage risk better than many other sectors.

If you’re buying or renewing insurance for a medical device manufacturer, it helps to understand how underwriters think. This guide explains the main factors insurers assess, the documents they typically request, and the practical steps that can improve your risk profile (and often your premium).

1) The insurer’s goal: predict frequency and severity

Insurers assess two things:

• How likely a claim is (frequency)
• How expensive a claim could be (severity)

In medical devices, severity can be high because claims may involve bodily injury, long-tail litigation, product recalls, regulatory action, and reputational damage. Underwriters therefore look for evidence that your business reduces both the chance of a defect and the impact if one occurs.

2) What you manufacture (and how it’s used)

The starting point is the device itself. Insurers will consider:

• Device type and intended use (diagnostic, therapeutic, implantable, software-driven, single-use, reusable)
• Patient contact and invasiveness (external vs invasive vs implantable)
• Where and by whom it’s used (hospital theatres, clinics, home use, consumer settings)
• User dependency (does safe use rely heavily on training and correct technique?)
• Failure modes (what happens if it fails—minor inconvenience, delayed diagnosis, serious injury?)

In simple terms: the more critical the device is to patient outcomes, the more insurers will want to see robust design controls, testing, and post-market surveillance.

3) Regulatory compliance and quality management systems

For UK medical device manufacturers, insurers expect strong governance around compliance. They will commonly ask about:

• Quality Management System (QMS) (often aligned to ISO 13485)
• Risk management process (often aligned to ISO 14971)
• UKCA/CE marking status and how conformity is maintained
• Technical documentation and change control
• Supplier controls and traceability
• Internal audits and management reviews
• CAPA process (Corrective and Preventive Actions)

Insurers aren’t auditing you like a regulator, but they do use these signals to judge how consistently you build safe products.

4) Design and development controls

Underwriters want confidence that design decisions are documented, tested, and reviewed. They may look for:

• Clear design inputs/outputs and documented verification/validation
• Human factors/usability work where relevant
• Software lifecycle controls for connected or software-enabled devices
• Clinical evaluation approach (where applicable)
• Change control discipline (how you assess and approve changes)

A common concern is “silent drift”—small changes over time (materials, suppliers, firmware, packaging) that increase risk without being fully assessed.

5) Manufacturing controls and process stability

Even a great design can fail if manufacturing is inconsistent. Insurers typically ask:

• How you control critical processes (sterilisation, cleanroom operations, welding, bonding, calibration)
• Process validation and ongoing monitoring
• Batch/lot traceability and record retention
• In-process and final QC checks
• Non-conformance handling and scrap/rework controls
• Equipment maintenance and calibration

If you use contract manufacturers, insurers will want to understand oversight: who owns the QMS, who signs off release, and how you audit the partner.

6) Sterilisation, contamination, and packaging risks

Where devices must be sterile or contamination-controlled, insurers focus on:

• Sterilisation method (e.g., gamma, EtO) and validation
• Environmental monitoring and cleanroom classification
• Bioburden controls and testing schedules
• Packaging design, seal integrity testing, and transit testing
• Storage conditions and shelf-life management

Packaging failures can drive expensive recalls even when the device itself is fine.

7) Supply chain resilience and supplier risk

Medical device supply chains can be fragile, especially for specialist components. Underwriters assess:

• Supplier qualification and audit programme
• Single-source dependencies and contingency plans
• Incoming inspection and material specifications
• Counterfeit component controls
• Lead times and inventory strategy

Supply chain issues can create both quality risk (substitution, rushed changes) and business interruption risk (production stops).

8) Post-market surveillance and vigilance

Insurers care about what happens after sale because many medical device claims arise from field performance. They may ask about:

• Complaint handling process and response times
• Trend analysis and escalation criteria
• Field safety corrective actions (FSCA) process
• Recall planning and decision-making
• Communication templates and distributor coordination

A strong post-market process reduces severity by catching issues early and limiting the number of affected units.

9) Claims history and near-miss learning

If you have prior claims, insurers will want:

• What happened, what it cost, and what was learned
• What changes were made to prevent recurrence
• Evidence those changes are embedded (not just “we retrained staff”)

Even without claims, insurers like to see a culture of reporting near misses, investigating root causes, and improving processes.

10) Contractual risk: what you agree to in writing

Your contracts can increase your exposure beyond what insurers expect. Underwriters may review:

• Indemnities and limitation of liability clauses
• Fitness-for-purpose wording
• Warranty terms
• Contractual assumption of another party’s liability
• Jurisdiction and governing law

If you supply into the US or sign contracts with aggressive indemnities, your product liability and professional liability risk can rise sharply.

11) Where you sell: territories and legal environments

Territory matters. Insurers will ask:

• UK-only, EU, US, or global distribution
• Use of distributors vs direct sales
• Any clinical trials or investigational use

The US is often treated as higher risk due to litigation costs and claim severity. Even if your sales are small, a single US claim can be significant.

12) Product liability, clinical responsibility, and “what if it’s advice?”

Medical device manufacturers can face different claim types:

• Product liability: defect in design/manufacture/warnings
• Errors & omissions / professional liability: incorrect instructions, specifications, or advice
• Clinical responsibility: where your staff are involved in training, set-up, or procedure support

If your team provides on-site support, training, or configuration, insurers will want clarity on what you do and don’t do—and how you document it.

13) Cyber and data risk for connected devices

If your device is connected, software-driven, or collects data, insurers increasingly ask about:

• Secure development practices and patching
• Vulnerability management and disclosure process
• Access controls, encryption, and logging
• Third-party libraries and supplier security n- Incident response planning

A cyber incident can become a safety incident, which can increase both cyber and product liability exposure.

14) Business interruption and property risk

Beyond liability, insurers assess whether a loss could stop production. They’ll look at:

• Building construction, fire protection, and housekeeping
• Sprinklers, alarms, and maintenance
• Storage of flammables and lithium batteries (where relevant)
• Critical machinery and single points of failure
• Utilities dependency (power, compressed air, clean water)
• Disaster recovery and alternative sites

If you operate cleanrooms or controlled environments, reinstatement time can be long—so business interruption sums insured and indemnity period matter.

15) People, training, and competence

Medical device manufacturing is process-driven, but people still matter. Underwriters may ask about:

• Training matrices and competency sign-off
• Supervision and segregation of duties
• Staff turnover in critical roles
• Use of temporary labour and how it’s controlled

A stable, well-trained team reduces error rates and improves consistency.

16) Documentation insurers may request

To assess risk, insurers and brokers often gather:

• Product overview and intended use
• QMS certifications and audit summaries
• Risk management summary (high level)
• Complaint/recall history (last 3–5 years)
• Sales split by territory and product line
• Top customers and contract terms (summary)
• Supplier/contract manufacturer overview
• Details of any clinical investigations
• Cyber/security overview for connected devices

You don’t usually need to share sensitive technical files. A well-prepared summary pack is often enough to demonstrate control.

17) What improves your terms (practical steps)

If you want to present well to insurers, focus on clarity and evidence:

• Keep a concise underwriting presentation (2–5 pages) explaining what you make, who uses it, and how you control risk
• Show how you manage design changes and supplier changes
• Demonstrate traceability and recall readiness
• Be transparent about incidents and show what you changed
• Review contracts for uninsurable indemnities and overly broad warranties
• For connected devices, document your patching and vulnerability process

The goal is to remove uncertainty. Underwriters price uncertainty.

18) Choosing the right insurance (and avoiding gaps)

Medical device manufacturers often need a combination of covers, such as:

• Product liability and public liability
• Employers’ liability
• Professional indemnity / errors & omissions (where advice/specification risk exists)
• Product recall / contamination (where appropriate)
• Cyber insurance (especially for connected devices)
• Property and business interruption
• Directors’ & officers’ liability (for management risk)

The right mix depends on your device type, territories, and contracts.

Conclusion

Insurers assess medical device manufacturing risk by looking for evidence of control: strong quality systems, disciplined design and change management, stable manufacturing processes, robust supplier oversight, and effective post-market surveillance. The better you can explain your product, your controls, and your learning culture, the easier it is for an underwriter to offer broad cover on fair terms.

If you’d like, I can turn your current process into a short underwriting presentation and a checklist of the exact questions insurers are likely to ask—so your next renewal is faster and smoother.